Markets / Mutual funds / Sectoral / Thematic
ITI Mutual Fund · Equity fund · Regular plan · IDCW
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Bars: this plan; the thin mark is the Sectoral / Thematic average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | +0.7 | |||||||||||
| 2025 | -7.9 | -8.1 | +7.3 | +0.7 | +1.0 | +2.5 | +2.2 | -4.1 | -1.6 | +3.6 | -0.7 | -3.1 |
| 2026 | -6.5 | +5.4 | -4.8 | +8.1 | +3.6 | +5.1 | +3.5 | +2.7 | -4.2 | -0.1 | +3.1 |
Each month's change in NAV (the current month to the latest NAV).
Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.
| Share of fund | 30 Sept 2026 | 31 Aug 2026 | Change |
|---|---|---|---|
| Stocks held | 99.3% | 99.3% | +0.04 |
| Cash & others | 0.7% | 0.7% | -0.04 |
| Top 10 stocks | 57.0% | 57.0% | +0.02 |
| Number of stocks | 37 | 37 | 0 |
Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.
| Holding | % of fund |
|---|---|
| Sun Pharmaceutical Industries Limited INE044A01036 | 11.96% |
| Divi's Laboratories Limited INE361B01024 | 9.51% |
| Apollo Hospitals Enterprise Limited INE437A01024 | 5.45% |
| Dr. Reddy's Laboratories Limited INE089A01031 | 4.78% |
| Torrent Pharmaceuticals Limited INE685A01028 | 4.78% |
| Max Healthcare Institute Limited INE027H01010 | 4.49% |
| Cipla Limited INE059A01026 | 4.19% |
| Laurus Labs Limited INE947Q01028 | 4.02% |
| Aurobindo Pharma Limited INE406A01037 | 4.01% |
| Mankind Pharma Limited INE634S01028 | 3.78% |
| Cohance Lifesciences Limited INE03QK01018 | 3.14% |
| Alkem Laboratories Limited INE540L01014 | 3.09% |
| Neuland Laboratories Limited INE794A01010 | 3.07% |
| Global Health Limited INE474Q01031 | 2.85% |
| Fortis Healthcare Limited INE061F01013 | 2.77% |
| Abbott India Limited INE358A01014 | 2.14% |
| Lupin Limited INE326A01037 | 2.04% |
| IPCA Laboratories Limited INE571A01038 | 1.94% |
| Sai Life Sciences Limited INE570L01029 | 1.87% |
| Shilpa Medicare Limited INE790G01031 | 1.61% |
| Aster DM Quality Care Limited INE914M01019 | 1.59% |
| Poly Medicure Limited INE205C01021 | 1.48% |
| Healthcare Global Enterprises Limited INE075I01017 | 1.47% |
| Piramal Pharma Limited INE0DK501011 | 1.27% |
| Anthem Biosciences Limited INE0CZ201020 | 1.25% |
| Shaily Engineering Plastics Limited INE151G01028 | 1.22% |
| Glenmark Pharmaceuticals Limited INE935A01035 | 1.13% |
| Gland Pharma Limited INE068V01023 | 1.03% |
| Supriya Lifescience Limited INE07RO01027 | 1.00% |
| Rainbow Childrens Medicare Limited INE961O01016 | 1.00% |
| GlaxoSmithKline Pharmaceuticals Limited INE159A01016 | 0.96% |
| Linde India Limited INE473A01011 | 0.92% |
| Biocon Limited INE376G01013 | 0.81% |
| Zydus Lifesciences Limited INE010B01027 | 0.73% |
| Metropolis Healthcare Limited INE112L01020 | 0.71% |
| Caplin Point Laboratories Limited INE475E01026 | 0.68% |
| Syngene International Limited INE398R01022 | 0.57% |
| Holding | % of fund |
|---|---|
| Net Receivables / (Payables) | 0.69% |
From the fund house's monthly portfolio (itiamc.com), as on 30 Sept 2026. Percentages are of the fund's net assets. Published about ten days after each month ends.
Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 30 Nov 2021).
| Fund size (average AUM, July - September 2026) | ₹266 cr across all plans · this plan ₹1.82 cr |
| Fund house | ITI Mutual Fund |
| Category | Equity · Sectoral / Thematic |
| Plan | Regular |
| Option | IDCW |
| Expense ratio (TER) | Direct 0.86% · Regular 2.57% (6 Nov 2026) |
| Exit load | If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50% Exit Load after completion of 3 months - NIL |
| Minimum investment | ₹5,000 · additional ₹1,000 |
| Scheme code (AMFI) | 149269 |
| ISIN | INF00XX01BM3 |
| NAV date | 6 Nov 2026 |
Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.
| Plan | NAV | 1 year |
|---|---|---|
| Direct · Growth | ₹20.0784 | +13.41% |
| Direct · IDCW | ₹20.0761 | +13.39% |
| Regular · Growth | ₹18.1899 | +11.40% |
| Fund | 1 year | 3 years (a year) |
|---|---|---|
| Nippon India Taiwan Equity Fund | +37.70% | +40.44% |
| HDFC Defence Fund | +19.63% | +33.69% |
| HDFC Pharma and Healthcare Fund | +26.81% | +30.17% |
| SBI HEALTHCARE OPPORTUNITIES FUND | +21.11% | +24.39% |
| HDFC Transportation and Logistics Fund | +8.74% | +23.82% |
| UTI - Healthcare Fund | +17.70% | +23.50% |
| Mirae Asset Healthcare Fund | +22.57% | +23.40% |
| BANK OF INDIA MANUFACTURING & INFRASTRUCTURE FUND | +16.15% | +22.19% |
All Sectoral / Thematic funds ranked › · Compare with others ›
Information only, not investment advice.
₹18.1899 as of 6 Nov 2026, from AMFI's official NAV data.
1 year: 11.40%, 3 years: 18.89% a year
Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.